Maven Securities’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Maven Securities’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-80,000	Closed	-$5.45M	–	1209
2022 Q3	$5.45M	Buy	+80,000	New	+$4.41M	0.1%	114
2021 Q1	–	Sell	-8,167	Closed	-$362K	–	1360
2020 Q4	$362K	Buy	+8,167	New	+$403K	0.04%	399

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maven Securities's GBT Position: Q4 2022 in Review

Maven Securities sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 80,000 shares — an estimated $5.45M sold.

Maven Securities first reported a position in GBT in Q4 2020 and held it in 2 quarters. The position peaked at $5.45M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Maven Securities reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Maven Securities sold 80,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $5.45M.
Maven Securities first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
Maven Securities's Global Blood Therapeutics, Inc. position peaked at $5.45M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Maven Securities's 13F filing for Q4 2022, filed 14 Feb 2023.